TY - JOUR
T1 - Being Precise About Precision Medicine
T2 - What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group
AU - Faulkner, Eric
AU - Holtorf, Anke Peggy
AU - Walton, Surrey
AU - Liu, Christine Y.
AU - Lin, Hwee
AU - Biltaj, Eman
AU - Brixner, Diana
AU - Barr, Charles
AU - Oberg, Jennifer
AU - Shandhu, Gurmit
AU - Siebert, Uwe
AU - Snyder, Susan R.
AU - Tiwana, Simran
AU - Watkins, John
AU - IJzerman, Maarten J.
AU - Payne, Katherine
PY - 2020/5
Y1 - 2020/5
N2 - Precision medicine is a dynamic area embracing a diverse and increasing type of approaches that allow the targeting of new medicines, screening programs or preventive healthcare strategies, which include the use of biologic markers or complex tests driven by algorithms also potentially taking account of patient preferences. The International Society for Pharmacoeconomics and Outcome Research expanded its current work around precision medicine to (1) describe the evolving paradigm of precision medicine with examples of current and evolving applications, (2) describe key stakeholders perspectives on the value of precision medicine in their respective domains, and (3) define the core factors that should be considered in a value assessment framework for precision medicine. With the ultimate goal of improving health of well-defined patient groups, precision medicine will affect all stakeholders in the healthcare system at multiple levels spanning the individual perspective to the societal perspective. For an efficient, timely and practical precision medicine value assessment framework, it will be important to address these multiple perspectives through building consensus among the stakeholders for robust procedures and measures of value aspects, including performance of precision mechanism; aligned reimbursement processes of precision mechanism and subsequent treatment; transparent expectations for evidence requirements and study designs adequately matched to the intended use of the precision mechanism and to the smaller target patient populations; recognizing the potential range of value-generation such as ruling-in and ruling-out decisions.
AB - Precision medicine is a dynamic area embracing a diverse and increasing type of approaches that allow the targeting of new medicines, screening programs or preventive healthcare strategies, which include the use of biologic markers or complex tests driven by algorithms also potentially taking account of patient preferences. The International Society for Pharmacoeconomics and Outcome Research expanded its current work around precision medicine to (1) describe the evolving paradigm of precision medicine with examples of current and evolving applications, (2) describe key stakeholders perspectives on the value of precision medicine in their respective domains, and (3) define the core factors that should be considered in a value assessment framework for precision medicine. With the ultimate goal of improving health of well-defined patient groups, precision medicine will affect all stakeholders in the healthcare system at multiple levels spanning the individual perspective to the societal perspective. For an efficient, timely and practical precision medicine value assessment framework, it will be important to address these multiple perspectives through building consensus among the stakeholders for robust procedures and measures of value aspects, including performance of precision mechanism; aligned reimbursement processes of precision mechanism and subsequent treatment; transparent expectations for evidence requirements and study designs adequately matched to the intended use of the precision mechanism and to the smaller target patient populations; recognizing the potential range of value-generation such as ruling-in and ruling-out decisions.
KW - UT-Hybrid-D
KW - Precision medicine and diagnostics
KW - Value frameworks
KW - Health technology assessment (HTA)
UR - http://www.scopus.com/inward/record.url?scp=85082835269&partnerID=8YFLogxK
U2 - 10.1016/j.jval.2019.11.010
DO - 10.1016/j.jval.2019.11.010
M3 - Article
C2 - 32389217
AN - SCOPUS:85082835269
VL - 23
SP - 529
EP - 539
JO - Value in health
JF - Value in health
SN - 1098-3015
IS - 5
ER -